THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is G8807B956. A total of 4 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 100 | $1,000 | 0.00% |
SIMPLEX TRADING, LLC | 6,100 | $55,000 | 0.00% |
JANE STREET GROUP, LLC | 32,000 | $290,000 | 0.00% |